The biology of photodynamic therapy

Physics in Medicine and Biology

Volumn 42, Issue 5, 1997, Pages 913-935

  Moore, James V ^a   West, Catharine M L ^a   Whitehurst, Colin ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TARGET CELL; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; CELLS; CRICETINAE; DOGS; ENDOTHELIUM; HUMANS; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PAPIO; PHOTOCHEMOTHERAPY; RATS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030952453     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/42/5/012     Document Type: Article

References (182)

1. Agrez M V, Wharen R E, Anderson R E, Laws E R, Ilstrup D M, Cortese D A, Shorter R G and Lieber M M 1983 Haematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma J. Surg. Oncol. 24 173-6
2. Aizawa K, Okunaka T, Ohtani T and Kawabe I I 1987 Localisation of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues Photochem. Photobiol. 46 789-93
3. Allardice J T, Abulafi A M, Grahn M F and Williams N S 1994 Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study Surg. Oncol 3 1-10
4. Allison B A, Pritchard P H and Levy J G 1994 Evidence for low-density lipoprotein-mediated uptake of benzoporphyrin derivative Br. J. Cancer 69 833-9
5. Amano T, Prout G R and Lin C 1988 lntratumour injection as a more effective means of porphyrin administration for photodynamic therapy J. Urol. 139 392-5
6. Andreoni A, Cubeddu R, Da Silvestri S, Laporta P, Ambesi-Impiombato F S, Esposito M, Mastrocinque M and Tramontano D 1983 Effects of laser irradiation on haematoporphyrin-treated normal and transformed thyroid cells in culture Cancer Res. 43 2076-80
7. Barr H and Bown S G 1992 Normal tissue damage following photodynamic therapy: are there biological advantages? Photodynamic Therapy - Basic Principles and Clinical Applications ed B Henderson and T J Dougherty (New York: Dekker) 201-16
8. Barr H, Chatlani P, Tralau C J, MacRobert A J, Boulos P B and Bown S G 1991 Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue Gut 32 517-23
9. Barr H, Tralau C J, MacRobert A J, Krasner N, Boulos P B, Clark C G and Bown S G 1987 Photodynamic therapy in the normal rat colon with phthalocyanine photosensitisation Br. J. Cancer 56 111-18
10. Baumgartner R, Fuchs N, Jocham D, Stepp H and Unsold E 1992 Pharmacokinetics of fluorescent polyporphyrin Photofrin II in normal rat tissue and rat bladder tumour Photochem. Photobiol. 55 569-74
11. Bellnier D A, Ho Y K, Pandey R K, Missert J R and Dougherty T J 1989 Distribution and elimination of Photofrin II in mice Photochem. Photobiol. 50 221-8
12. Bellnier D A and Lin C W 1985 Photosensitisation and split-dose recovery in cultured human urinary bladder carcinoma cells containing non-exchangeable haematoporphyrin derivative Cancer Res. 45 2507-11
13. Ben-Hur E, Fujihara T, Suzuki F and Elkind M M 1987a Genetic toxicology of the photosensitisation of Chinese hamster cells by phthalocyanines Photochem. Photobiol. 45 227-30
14. Ben-Hur E, Heldman E, Crane S W and Rosenthal I 1988a Release of clotting factors from photosensitised endothelial cells: a possible trigger for blood vessel occlusion by photo-dynamic therapy FEBS Lett. 236 105-8
15. Ben-Hur E and Rosenthal I 1985 Factors affecting the photokilling of cultured Chinese hamster cells by phthalocyanines Radiat. Res. 103 403-9
16. Ben-Hur E, Rosenthal I and Leznoff C C 1988b Recovery of Chinese hamster cells following photosensitisation by zinc tetrahydroxyphthalocyanine J. Photochem. Photobiol. B 2 243-52
17. Ben-Hur E, Siwecki J A, Newman H C, Crane S W and Rosenthal I 1987c Mechanism of uptake of sulphonated metallophthalocyanines by cultured mammalian cells Cancer Lett. 38 215-22
18. Berenbaum M C, Hall G W and Hoyes A D 1986 Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action Br. J. Cancer 53 81-9
19. Bergstrom L C, Vucenik I, Hagen I K, Chemomorsky S A and Poretz R D 1994 In vitro photocytotoxicity of lysosomotropic immunoliposomes containing pheophorbide a with human bladder carcinoma cells J. Photochem. Photobiol. B 24 17-23
20. Berns M W et al 1982 In vitro cellular effects of haematoporphyrin derivative Cancer Res. 42 2325-9
21. Berns M W, Wilson M, Rentzepis P, Bums R and Wile A 1983 Cell biology of haematoporphyrin derivative (HPD) Lasers Surg. Med. 2 261-6
22. Bolin F P, Preuss L E and Cain B W 1984 A comparison of spectral transmittance for several mammalian tissues: effects at PRT frequencies Porphyrin Localisation and Treatment of Tumours ed D R Doiron and C J Gomer (New York: Liss) pp 211-25
23. Bohmer R M and Morstyn G 1985 Uptake of haematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature and cell size Cancer Res. 45 5328-34
24. Bown S G, Tralau C J, Coleridge-Smith P D, Akdemir D and Wieman T J 1986 Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver Br. J. Cancer 54 43-52
25. Bremner J C, Adams G E, Pearson J K, Stratford I J, Bedwell J, Bown S G, MacRobert A J and Phillips D 1992 Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145 Br. J. Cancer 66 1070-6
26. Ceckler T L, Gibson S L, Hilf R and Bryant R G 1990 In situ assessment of tumour vascularity using fluorine NMR imaging Magn. Reson. Med. 13 416-33
27. Ceckler T L, Gibson S L, Kennedy S D, Hilf R and Bryant R G 1991 Heterogeneous tumour response to photodynamic therapy assessed by in vivo localised 31P-NMR spectroscopy Br. J. Cancer 63 916-22
28. Chan W-S, Marshall J-F, Lam G Y and Hart I R 1988 Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminium sulphonated phthalocyanine in mice bearing transplantable tumours Cancer Res. 48 3040-4
29. Chan W-S, West C M L, Moore J V and Hart I R 1991 Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours Br. J. Cancer 64 827-32
30. Chapman J D, McPhee M S, Walz N, Chetner M P, Stobbe C C, Soderlind K, Arnfield M, Meeker B E, Trimble L and Allen P S 1991 Nuclear magnetic resonance spectroscopy and sensitiser-adduct measurements of photodynamic therapy-induced ischaemia in solid tumours J. Natl Cancer lnst. 83 1650-9
31. Chopp M, Glasberg M R, Riddle J M, Hetzel F W and Welch K M A 1987 Photodynamic therapy of normal cerebral tissue in the cat: a noninvasive model for cerebrovascular thrombosis Photochem. Photobiol. 46 103-8
32. Chopp M, Hetzel F W and Jiang Q 1990 Dose-dependent metabolic response of mammary carcinoma to photodynamic therapy Radiat. Res. 121 288-94
33. Christensen T, Moan J, Sandquist T and Smedshammer L 1984 Multicellular spheroids as an in vitro model system for photoradiation therapy in the presence of Hpd Porphyrin Localisation and Treatment of Tumours ed D R Doiron and C J Gomer (New York: Liss) pp 381-90
34. Cincotta L, Foley, J W and Cincotta A H 1993 Phototoxicity, redox behaviour and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells Cancer Res. 53 2571-80
35. Crute J J, Wahl A F, Bambara R A, Murant R S, Gibson S L and Hilf R 1986 Inhibition of mammalian DNA polymerase by haematoporphyrin derivative and photoradiation Cancer Res. 46 153-9
36. Dartsch P C, Coppenrath E, Coppenrath K and Ischinger T 1993 Photodynamic therapy of vascular stenosis: results from cell culture studies on human endothelial cells Coron. An. Dis. 4 207-13
37. Davies C L, Ranheim T, Rofstad E K, Moan J and Lindmo T 1988 Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment Br. J. Cancer 58 306-13
38. Deliconstantinos G, Villiotou V, Fassitsas C 1992 Ultraviolet-irradiated human endothelial cells elaborate nitric oxide that may evoke vasodilatory response J. Cardiovasc. Pharmacol. 20 (Supplement 12) S63-5
39. Dellian M, Abels C, Kuhnle G E and Goetz A E 1995 Effects of photodynamic therapy on leukocyte-endothelium interaction: differences between normal and tumour tissue Br. J. Cancer 72 1125-30
40. Dereski M O, Chopp M, Garcia J H and Hetzel F W 1991 Depth measurements and histo-pathological characterisation of photodynamic therapy generated normal brain necrosis as a function of incident optical energy dose Photochem. Photobiol. 54 109-12
41. Diwu Z and Lown J W 1994 Phototherapeutic potential of alternative photosensitisers to porphyrins Pharmacol. Ther. 63 1-35
42. Dodd N J F, Moore J V, Poppitt D G and Wood B 1989 In vivo magnetic resonance imaging of the effects of photodynamic therapy Br J. Cancer 60 164-7
43. Doiron D R, Svaasand L O and Profio A E 1983 Light dosimetry in tissue: applications in photoradiation therapy Adv. Exp. Med. Biol. 160 63-76
44. Eggert H R and Blazek V 1987 Optical properties of human brain tissue, meninges and brain tumours in the spectral range of 200 to 900 nm Neurosurgery 21 459-64
45. Elmer E B, Wood W C, Cohen A M and Bamberg M 1987 Effect of route of administration on the selectivity of haematoporphyrin derivative for tumour tissue J. Surg. Oncol. 34 113-19
46. Estey E P, Brown K, Diwu Z, Liu J, Lown J W, Miller G G, Moore R B, Tulip J and McPhee M S 1996 Hypocrellins as photosensitisers for photodynamic therapy: a screening evaluation and pharmacokinetic study Cancer Chemother. Pharmacol. 37 345-50
47. Evensen J F and Moan J 1982 Photodynamic action and chromosomal damage: a comparison of haematoporphyrin derivative (HpD) and light with x-irradiation Br. J. Cancer 45 456-65
48. Evensen J F, Moan J and Winkelman J W 1987 Toxic and phototoxic effects of tetraphenyl-porphinesulphonate and haematoporphyrin derivative in vitro Int. J. Radiat. Biol. Phys. Chem. Med. 51 477-91
49. Fingar V H, Mang T S and Henderson B W 1988 Modification of photodynamic therapy-induced hypoxia by Fluosol-DA (20%) and Carbogen breathing in mice Cancer Res. 48 3350-4
50. Fingar V H, Wieman T J and Doak K W 1991a Changes in tumour interstitial pressure induced by photodynamic therapy Photochem. Photobiol. 53 763-8
51. _1991b Mechanistic studies of PDT-induced vascular damage: evidence that eicosanoids mediate this process Int. J. Radiat. Biol. 60 303-9
52. Fingar V H, Wieman T J, Karavalos P S, Doak K W, Quellet R and van Lier J E 1993 The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumour response Photochem. Photobiol. 58 251-8
53. Fingar V H, Wieman T J, Wiehle S A and Cerrito P B 1992 The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion Cancer Res. 52 4914-21
54. Foster T A, Primavera M.C, Marder V J, Hilf R and Sporn L A 1991 Photosensitised release of von Willebrand factor from cultured human endothelial cells Cancer Res. 51 3261-6
55. Foster T H, Hartley D F, Nichols M G and Hilf R 1993 Fluence rate effects in photodynamic therapy of multicell tumour spheroids Cancer Res. 53 1249-54
56. Gaffney J, West D C, Arnold F, Sattar A and Kumar S 1985 Differences in the uptake of modified low density lipoproteins by tissue cultured endothelial cells J. Cell Sci. 79 317-25
57. Gilissen M J, van de Merbel de Wit E A, Star W M, Koster J F and Sluite W 1993 Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas Cancer Res. 53 2548-52
58. Gomer C J, Doiron D R, Rucker N, Razum N J and Fountain S W 1984 Examination of action spectrum, dose rate and mutagenic properties of haematoporphyrin derivative photoradiation therapy. Porphyrin Localisation and Treatment of Tumours ed D R Doiron and C J Gomer (New York: Liss) pp 459-69
59. Gomer C J, Ferrario A, Rucker N, Wong S and Lee S 1991 Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitisation Cancer Res. 51 6574-9
60. Gomer C J, Rucker N, Banerjee A and Benedict W F 1983 Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to haematoporphyrin derivative photoradiation, ionising radiation, or ultraviolet radiation Cancer Res. 43 2622-7
61. Gomer C J, Rucker N, Ferrario A and Murphree A L 1986 Expression of potentially lethal damage in Chinese hamster cells exposed to haematoporphyrin derivative Cancer Res. 46 3348-52
62. Gomer C J, Rucker N and Murphree A L 1988a Transformation and mutagenic potential of porphyrin photodynamic therapy in mammalian cells Int. J. Radiat. Biol. Phys. Chem. Med. 53 797-811
63. _1988b Differential cell photosensitivity following porphyrin photodynamic therapy Cancer Res. 48 4539-42
64. _1985a Examination of potentially lethal damage in cells treated with haematoporphyrin derivative and red light Adv. Exp. Med. Biol. 193 147-53
65. Gomer C J, Rucker N, Razum N J and Murphree A L 1985b In vitro and in vivo light dose rate effects related to haematoporphyrin derivative photodynamic therapy Cancer Res. 45 1973-7
66. Gomer C J, Rucker N and Wong S 1990 Porphyrin photosensitivity in cell lines expressing a heat-resistant phenotype Cancer Res. 50 5365-8
67. Grant W E, Buonaccorsi G, Speight P M, MacRobert A J, Hoper C and Bown S G 1995 The effect of photodynamic therapy on the mechanical integrity of normal rabbit carotid arteries Laryngoscope 105 867-71
68. Hamblin M R and Newman E L 1994 Photosensitiser targeting in photodynamic therapy. II Conjugates of haematoporphyrin with serum lipoproteins J. Photochem. Photobiol. B 26 147-57
69. Hamilton D, McKean J D S, Tulip J, Boisvert D and Cummins J 1986 In vitro photoradiation therapy of the rat 9L gliosarcoma J. Neurosurg. 64 775-9
70. Hanania J and Malik Z 1992 The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitisation of human K562 leukaemia cells Cancer Lett. 65 127-31
71. 18FDG Quantitative Imaging in Oncology ed K Faulkner et al (London: British Institute of Radiology) pp 9-13
72. Haylett A K, Forbes E, MacLennan A, Truscott T G and Moore J V 1996 Novel asymmetric photosensitisers: an in vitro study Cancer Lett. 105 187-93
73. Haylett A K, Ross S, Truscott T G and Moore J V 1995 Pharmacokinetic and therapeutic outcome in melanoma cells, of the administration of symmetric and asymmetric cationic photosensitisers Cancer Lett. 88 191-9
74. He X-Y, Sikes R A, Thomsen S, Chung L W K and Jacques S L 1994 Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines Photochem. Photobiol. 59 468-73
75. Henderson B W, Bellnier D A, Ziring B and Dougherty T J 1983 Aspects of the cellular uptake and retention of haematoporphyrin derivative and their correlation with the biological response to PRT in vitro Adv. Exp. Med. Biol. 160 129-38
76. Henderson B W, Owczarczak B, Sweeney J and Gessner T 1992 Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation Photochem. Photobiol. 56 513-21
77. Henderson B W, Vaughan L, Bellnier D A, van Leengoed H, Johnson P G and Oseroff A R 1995 Photosensitisation of murine tumour, vasculature and skin by 5-aminolaevulinic acid-induced porphyrin Photochem. Photobiol. 62 780-9
78. Henderson B W, Waldow S M, Mang T S, Potter R, Malone P B and Dougherty T J 1985 Tumour destruction and kinetics of tumour cell death in two experimental mouse tumours following photodynamic therapy Cancer Res 45 572-6
79. Herrmann K S 1983 Platelet aggregation induced in the hamster cheek pouch by a photo-chemical process with excited fluorescein isothyocyanate-dextran Microvasc. Res. 26 238-49
80. Hilf R, Leakey P B, Sollott S J and Gibson S L 1983 Photodynamic inactivation of R3230AC mammary carcinoma in vitro with haematoporphyrin derivative: effects of dose, time and serum on uptake and phototoxicity Photochem. Photobiol. 37 633-42
81. Hill J S, Kaye A H, Sawyer W H, Morstyn G, Medison P D and Stylli S S 1990 Selective uptake of haematoporphyrin derivative into human cerebral glioma Neurosurgery 26 248-4
82. Hirsch B D, Walz N C, Meeker B E, Arnfield M R, Tulip J, McPhee M S and Chapman J D 1987 Photodynamic therapy-induced hypoxia in rat tumours and normal tissues Photochem. Photobiol. 46 847-52
83. Hisazurni H, Miyoshi N, Ueki O and Nakajima K 1984 Cellular binding of haematoporphyrin derivative (HpD) in human bladder cancer cell line: KK-47 Prog. Clin. Biol. Res. 170 443-57
84. Hua Z, Gibson S L, Foster T H and Hilf R 1995 Effectiveness of delta-aminolaevulinic acid-induced protoporphyrin as a photosensitiser for photodynamic therapy in vivo Cancer Res. 55 1723-31
85. Jamieson C H, McDonald W N and Levy J G 1990 Preferential uptake of benzoporphyrin derivative by leukaemic versus normal cells Leuk. Res. 14 209-19
86. Jeeves W P, Wilson B C, Firnau G and Brown K 1985 Studies of HPD and radiolabelled HPD in vivo and in vitro Adv. Exp. Med. Biol. 193 51-67
87. Jeeves W P, Wilson B C, Smith P, Ens K and Spiegl P 1987 Growth delay studies of the response of V-79 multicell spheroids exposed to DHE and red light Photochem. Photobiol. 46 723-8
88. 1H magnetic resonance imaging of normal brain tissue response to photodynamic therapy Neurosurgery 29 538-46
89. Jori G and Reddi E 1993 The role of lipoproteins in the delivery of tumour-targeting photo-sensitisers Int. J. Biochem. 25 1369-75
90. Kakehashi A, Akiba J, Ueno N and Chakrabarti B 1993 Evidence for singlet oxygen-induced cross-links and aggregation of collagen Biochem. Biophys. Res. Commun. 196 1440-6
91. Kaye A H and Hill J S 1993 Photodynamic therapy of brain tumours Ann. Acad. Med. Singapore 22 (Supplement 3) 470-81
92. Kennedy S D, Szczepaniak L S, Gibson S L, Hilf R, Foster T H and Bryant R G 1994 Quantitative MRI of Gd-DTPA uptake in tumours: response to photodynamic therapy Magn. Reson. Med. 31 292-301
93. Kessel D 1977 Effects of photoactivated porphyrins at the cell surface of L1210 cells Biochemistry 16 3443-9
94. _1981 Transport and binding of haematoporphyrin derivative and related porphyrins by murine leukaemia L1210 cells Cancer Res. 41 1318-23
95. _1986 Sites of photosensitisation by derivatives of haematoporphyrin Photochem. Photobiol. 44 489-93
96. Kessel D, Lo J, Jeffers R, Fowlkes J B and Cain C 1995 Modes of photodynamic vs sonodynamic cytotoxicity J. Photochem. Photobiol. B 28 219-21
97. Kessel D and Woodburn K 1995 Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent Br. J. Cancer 71 306-10
98. Kick G, Messer G, Goetz A, Plewig G and Kind P 1995 Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding Cancer Res. 55 2373-9
99. Korbelik M and Krosl G 1994 Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply Br. J. Cancer 70 604-10
100. Korbelik M, Krosl G, Olive P L and Chaplin D J 1991 Distribution of Photofrin between tumour cells and tumour associated macrophages Br. J. Cancer 64 508-12
101. Kostron H, Bellnier D A, Lin C W, Swartz M R and Martuza R L 1986 Distribution, retention and phototoxicity of haematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection J. Neurosurg. 64 768-74
102. Kriegmair M, Baumgartner R, Lumper W, Waidelich R and Hofstetter A 1996 Early clinical experience with 5-aminolaevulinic acid for the photodynamic therapy of superficial bladder cancer Br. J. Urol. 77 667-71
103. Kvam E and Moan J 1990 A comparison of three photosensitisers with respect to efficiency of cell inactivation, fluorescence quantum yield and DNA strand breaks Photochem. Photobiol. 52 769-73
104. Laukka M A, Wang K K and Bonner J A 1994 Apoptosis occurs in lymphoma cells but not in hepatoma cells following ionising radiation and photodynamic therapy Digest. Dis. Sci. 39 2467-75
105. Lee L K, Whitehurst C, Pantelides M L and Moore J V 1995 In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland Photochem. Photobiol. 62 882-6
106. Leunig M, Goetz A E, Gamarra F, Zetterer G, Messmer K and Jain R K 1994a Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster Br. J. Cancer 69 101-3
107. Leunig A, Staub F, Peters J, Heimann A, Csapo C, Kempski O and Goetz A E 1994b Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes in cell volume in different cell lines Eur. J. Cancer A 30 78-83
108. Leunig A, Staub F, Peters J, Heimann A, Kempski O and Goetz A E 1993 An in vitro model to study cellular photosensitiser uptake and photodynamic dose-response relationships of tumour cells Res. Exp. Med. Berl. 193 361-70
109. Levy JG 1994 Photosensitisers in photodynamic therapy Semin. Oncol. 6 (Supplement 15) 4-10
110. Lim H W 1989 Effects of porphyrins on skin Photosensitising Compounds: their Chemistry, Biology and Clinical Use ed G Bock and S Harnett (Chichester: Wiley) pp 148-53
111. Lim H W, Young L, Hagan M and Gigli I 1985 Delayed phase of haematoporphyrin induced phototoxicity: modulation by complement, leukocytes, and antihistamines J. Invest. Dermatol. 84 114-17
112. Lin G S, Al-Dakan A A and Gibson D P 1986 Inhibition of DNA and protein synthesis and cell division by photoactivated haematoporphyrin derivative in hamster ovary cells Br. J. Cancer 53 265-9
113. Lindsay E A, Berenbaum M C, Bonnett R and Thomas D G T 1991 Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive Br. J. Cancer 63 242-6
114. Liu Y H, Hawk R M and Ramaprasad S 1995 In vivo relaxation time measurements on a murine tumour model -prolongation of T1 after photodynamic therapy Magn. Reson. Imaging. 13 251-8
115. Luna M C, Ferrario A, Rucker N and Gomer C J 1995 Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumour cells Cancer Res. 55 1820-3
116. Ma L, Moan J and Berg K 1994 Evaluation of a new photosensitiser, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitisers Int. J. Cancer 57 883-8
117. Marcus S L and Dugan M H 1992 Global status of clinical photodynamic therapy: the registration process for a new therapy Lasers Surg. Med. 12 318-24
118. 2H NMR spectroscopy NMR Biomed. 3 64-70
119. McMahon K S, Wieman T J, Moore P H and Fingar V H 1994 Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage and tumour response Cancer Res. 54 5374-9
120. Miller F N, Sims D E, Schuschke D A and Abney D L 1992 Differentiation of light-dye effects in the microcirculation Microvasc. Res. 44 166-84
121. Moan J and Christensen T 1979 Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and dose fractionation Cancer Lett. 6 331-5
122. Moan J, Peng Q, Evensen J F, Berg K, Western A and Rimington C 1987 Photosensitising efficiencies, tumour-and cellular uptake of different photosensitising drugs relevant for photodynamic therapy of cancer Photochem. Photobiol. 46 713-21
123. Moan J, Waksvik H and Christensen T 1980 DNA single-strand breaks and sister chromatid exchanges induced by treatment with haematoporphyrin and light or by X-rays in human NHIK 3025 cells Cancer Res. 40 2915-18
124. Moore J V, Dodd N J F and Wood B 1989 Proton nuclear magnetic resonance imaging as a predictor of the outcome of photodynamic therapy of tumours Br. J. Radiol. 62 869-70
125. Moore J V, Keene J and Land E J 1986 Dose-response relationships for photodynamic injury to murine skin Br. J. Radiol. 59 257-61
126. Morton C A, Whitehurst C, Moseley H, Moore J V and MacKie R M 1995 Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer Lasers Med. Sci. 10 165-71
127. Musser D A 1988 The effect of photodynamic therapy (PDT) on glucose levels within the SMT-F mouse tumour Res. Commun. Chem. Pathol. Pharmacol. 60 361-9
128. Musser D A, Datta-Gupta N and Fiel R J 1980 Inhibition of DNA dependent RNA synthesis by porphyrin photosensitisers Biochem. Biophys. Res. Commun. 97 918-25
129. Nelson J S, Liaw L-H and Berns M W 1987 Tumour destruction in photodynamic therapy Photochem. Photobiol. 46 829-35
130. Noodt B B, Berg K, Stokke T, Peng Q and Nesland J M 1996 Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX Br J. Cancer 74 22-8
131. Nseyo U O, Mang T S and Potter W R 1986 Dihaematoporphyrin ether clearance in primate bladders J. Urol. 136 1363-6
132. Oenbrink G, Jurgenlimke P and Gabel D 1988 Accumulation of porphyrins in cells: influence of hydrophobicity, aggregation and protein binding Photochem. Photobiol. 48 451-6
133. Ogawa S, Clauss M, Kuwabara K, Shreeniwas R, Butura C. Koga S and Stern D 1991 Hypoxia induces endothelial cell synthesis of membrane-associated proteins Proc. Natl Acad. Sci. USA 88 9897-901
134. Pantelides M L, Moore J V and Blacklock N J 1989 A comparison of serum kinetics and tissue distribution of Photofrin II following intravenous and intraperitoneal injection in the mouse Photochem. Photobiol. 49 67-70
135. Pantelides M L, Whitehurst C, Moore J V, King T A and Blacklock N J 1990 Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland J. Urol. 143 398-401
136. Pass H I, Evans S, Matthews W A, Perry R, Venzon D, Roth J A and Smith P 1991 Photodynamic therapy of oncogene-transformed cells J. Thorac. Cardiovasc. Surg. 101 795-9
137. Pelton J J, Kowalyshyn M J and Keller S M 1992 Intrathoracic organ injury associated with photodynamic therapy J. Thorac. Cardiovasc. Surg. 103 1218-23
138. Peng Q, Evensen J F, Rimington C and Moan J 1987 A comparison of different photosensitising dyes with respect to uptake by C3H tumours and tissues of mice Cancer Lett. 36 1-10
139. Peng Q, Moan J, Warloe T, Nesland J M and Rimington C 1992 Distribution and photosensitising efficiency of porphyrins induced by application of exogenous 5-aminolaevulinic acid in mice bearing mammary carcinoma Int. J. Cancer 53 433-43
140. Penning L C, Lagerberg J W, van Dierendonck J H, Comelisse C J, Dubbelman T M and van Steveninck J 1994 The role of DNA damage and inhibition of poly(ADP-ribosyl)ation in loss of clonogenicity of murine L929 fibroblasts, caused by photodynamically induced oxidative stress Cancer Res. 54 5561-7
141. Pope A J, Masters J R and MacRobert A J 1990 The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro Urol. Res. 18 267-70
142. Reed M W R, Schuschke D A, Ackermann D M, Harty J I, Wieman T J and Miller F N 1989 The response of the rat urinary bladder microcirculation to photodynamic therapy J. Urol. 142 865-8
143. Rerko R M, Clay M E, Antunez A R, Oleinick N L and Evans H H 1992 Photofrin II photosensitisation is mutagenic at the tk locus in mouse L5178Y cells Photochem Photobiol 55 75-80
144. Richelli F 1995 Photophysical properties of porphyrins in biological membranes J. Photochem. Photobiol. B 29 109-18
145. Richelli F, Gobbo S, Jori G, Moreno G, Vinzens F and Salet C 1993 Photosensitisation of mitochondria by liposome-bound porphyrins Photochem. Photobiol. 58 53-8
146. Roberts W G and Berns M W 1989 In vitro photosensitisation 1. Cellular uptake and subcellular localisation of mono-L-aspartyl chlorin e6, chloro-aluminium sulphonated phthalocyanine and Photofrin II Lasers Surg. Med. 9 90-101
147. Roberts W G and Hasan T 1992 Role of neovasculature and vascular permeability on the tumour retention of photodynamic agents Cancer Res. 52 924-30
148. Romanos G E, Pelekanos S and Strub J-R 1995 Effects of Nd:YAG laser on wound healing Lasers Surg. Med 16 368-79
149. Rosenblum W I and El-Sabban F 1987 Platelet aggregation in the cerebral microcirculation Circ. Res. 40 320-8
150. Rosenthal I and Ben-Hur E 1989 Phthalocyanines in photobiology Phthalocyanines: Properties and Applications ed C C Leznoff and A B P Lever (New York: VCH) p 397
151. Salet C and Moreno G 1981 Photodynamic effects of haematoporphyrin on respiration and calcium uptake in isolated mitochondria Int. J. Radiat. Biol. 39 227-30
152. Schneckenburger H, Ruck A, Bartos B and Steiner R 1988 Intracellular distribution of photosensitising porphyrins measured by video-enhanced fluorescence microscopy J. Photochem. Photobiol. B 2 355-63
153. Schroder T, Chen I-W, Sperling M, Bell R H, Bracken K and Joffe S N 1988 Haematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma J. Surg. Oncol. 38 4-9
154. Selman S H, Keck R W and Hampton J A 1996 Transperineal photodynamic ablation of the canine prostate J. Urol. 156 258-60
155. Sharkey S M, Wilson B C, Moorehead R and Singh G 1993 Mitochondrial alterations in photodynamic therapy-resistant cells Cancer Res. 53 4994-9
156. Shopova M, Mantareva V, Krastev K, Hadjiolov D, Milev A, Spirov K, Jori G and Ricchelli F 1992 Comparative pharmacokinetic and pharmacodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma J. Photochem. Photobiol B: Biol. 16 83-9
157. Singh G, Jeeves W P, Wilson B C and Jang D 1987 Mitochondrial photosensitisation by Photofrin II Photochem. Photobiol. 46 645-9
158. Specht K G and Rodgers M A J 1991 Plasma membrane depolarisation and calcium influx during cell injury by photodynamic action Biochim. Biophys. Acta 1070 60-8
159. Sprik S A, Sullivan M J and Carey T E 1988 In vitro photosensitisation of human head and neck squamous cancer cells by dihaematoporphyrin ether Otolaryngol. Head Neck Surg. 99 28-37
160. Stern S J, Craig J R, Flock S and Small S 1992 Effect of aspirin on photodynamic therapy utilising chloroaluminum sulfonated phthalocyanine (CASP) Lasers Surg. Med. 12 494-9
161. Stummer W, Gotz C, Hassan A, Heimann A and Kempski O 1993 Kinetics of Photofrin II in perifocal brain oedema Neurosurgery 33 1075-81
162. Tralau C J, MacRobert A J, Coleridge-Smith P D, Barr H and Bown S G 1987 Photodynamic therapy with phthalocyanine sensitisation: Quantitative studies in a transplantable rat fibrosarcoma Br. J. Cancer 55 389-95
163. Tralau C J, Young A R, Walker N P J, Vernon D I, MacRobert A J, Brown S B and Bown S G 1989 Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (ALSPc): a comparative study Photochem. Photobiol. 49 305-12
164. Tromberg B J, Orenstein A, Kimel S, Barker S J, Hyatt J, Nelson J S and Berns M W 1990 In vivo tumour oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy Photochem. Photobiol. 52 375-85
165. van Geel I P, Oppelaar H, Rijken P F, Bernsen H J, Hagenmeier N E, van der Kogel A J, Hodgkiss R J and Stewart FA 1996 Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy Br. J. Cancer 73 288-93
166. van Gemert J C, Berenbaum M C and Gijsbers G H M 1985 Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative Br. J. Cancer 52 43-9
167. van Setten G B, Koch J W, Tervo K, Lang G K and Tervo I 1992 Expression of tenascin and ftbronectin in the rabbit cornea after excimer laser surgery Graefe's Arch. Clin. Exp. Ophthalmol. 230 178-83
168. Waterfield E M, Renke M E, Smits C B, Gervais M D, Bower R D, Stonefield M S and Levy J G 1994 Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro Photochem. Photobiol. 60 383-7
169. West C M L 1989 Size-dependent resistance of human tumour spheroids to photodynamic treatment Br. J. Cancer 59 510-14
170. West C M L and Moore J V 1988 Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS Int. J. Radiat. Biol. 54 621-34
171. _1989a The photodynamic effects of Photofrin II, haematoporphyrin derivative, haematoporphyrin, and tetrasodium-meso-tetra(4-sulphonatophenyl) porphine in vitro: clonogenic cell survival and uptake studies Photochem. Photobiol. 49 169-74
172. _1989b Flow cytometric analysis of intracellular haematoporphyrin derivative in human tumour cells and multicellular spheroids Photochem. Photobiol. 50 665-9
173. _1992 Mechanisms behind the resistance of spheroids to photodynamic treatment: a flow cytometry study Int. J. Radiat. Biol. 55 425-30
174. West C M L, West D C, Kumar S and Moore J V 1990 A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states Int. J. Radiat. Biol. 58 145-56
175. West C M L, West D C and Moore J V 1991 Low-density lipoprotein uptake and the sensitivity to photodynamic treatment of cultured endothelial cells Int. J. Radiat. Biol. 60 25-8
176. Whitehurst C, Byrne K and Moore J V 1993 Development of an alternative
177. Whitehurst C and Moore J V 1996 Development of an alternative light source to lasers for biomedical applications SPIE Proc. 2629 291-8
178. Whitehurst C, Pantelides M L, Moore J V, Brooman P J C and Blacklock N J 1994 In vivo laser light distribution in human prostatic carcinoma J. Urol. 151 1411-15
179. Williams R D and Runge T C 1987 Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II Photochem. Photobiol. 46 733-7
180. Wooten R S, Ahlquist D A, Anderson R E, Carpenter H A, Pemberton J H, Cortese D A and llstrup D M 1989 Localisation of haematoporphyrin derivative to human colorectal cancer Cancer 64 1569-76
181. Yoshida Y, Dereski O, Garcia J H, Hetzel F W and Chopp M 1992 Photoactivated Photofrin II: astrocytic swelling precedes endothelial injury in rat brain, J. Neuropathol. Exp. Neurol. 51 91-100
182. Zaidi S I A, Oleinick N L, Zaim M T and Mukhtar H 1993 Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumours in C3H mice: electron microscopic, histopathologic and biochemical evidence Photochem. Photobiol. 58 771-6